about
Functional anatomy of thalamus and basal gangliaPotent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation.Alpha-theta effects associated with ageing during the Stroop test.A New Perspective for the Training Assessment: Machine Learning-Based Neurometric for Augmented User's Evaluation.Evidence of oligodendrogliosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.Critical evaluation of the anatomical location of the Barrington nucleus: relevance for deep brain stimulation surgery of pedunculopontine tegmental nucleus.Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonismAlterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeysIFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's diseaseMemantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus.Retinal aging in the diurnal Chilean rodent (Octodon degus): histological, ultrastructural and neurochemical alterations of the vertical information processing pathwayParkinson's disease and inflammatory changes.The multifaceted role of metalloproteinases in physiological and pathological conditions in embryonic and adult brains.Parkinson's disease and autophagy.ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo.CD20, CD3, and CD40 ligand microclusters segregate three-dimensionally in vivo at B-cell-T-cell immunological synapses after viral immunity in primate brainEffects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: towards translational challenge models for drug discovery in Alzheimer's disease.Octodon degus: a model for the cognitive impairment associated with Alzheimer's disease.Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans.Functional role of Barrington's nucleus in the micturition reflex: relevance in the surgical treatment of Parkinson's disease.Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions.Inflammation in Parkinson's disease: role of glucocorticoids.Transcranial Magnetic Stimulation on Rodent Models.Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease.Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging.On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation.The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease.Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states.Distribution of galanin-like immunoreactivity in the human brain.Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum.Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys.Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system.Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys.Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.Measurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity.MPTP administration increases plasma levels of acute phase proteins in non-human primates (Macaca fascicularis).Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism.
P50
Q30053710-809B8D59-8489-4620-985F-36EB2544F4A0Q30549650-FD7200E4-2F53-4F5A-830C-53169D34F1EBQ33670409-6721A174-3779-42AD-96AA-060975D8F562Q33790152-44B3D876-A5E9-4D49-9845-0055340D8E55Q34207470-2F0EDD46-0639-4BC9-B6BE-969E1AFBE826Q34754457-538CC678-1E6B-40B5-A465-F3ADD31BE36EQ34835467-88F4649E-25BD-45EB-BD97-87EA64DC6B5BQ34990005-FCAD9A3C-992B-49F4-94C3-8583168562C5Q35064839-8ECBD548-6A01-440C-B0EA-A62B72692935Q35176569-77B6FD4D-160F-4868-8856-F030406ADFC7Q35516360-C77B964C-53D6-4E6A-ACFB-1B4560F9299FQ35625447-6FCBB6CF-490D-45A0-AAAA-DB1D532AA94CQ36105131-62F9E856-ECC9-4D0A-B23A-75F3573DDBF7Q36355428-58014C09-847E-44C4-8A8A-9294DEC8411BQ36382599-DA77B1EF-DEDC-42A2-9CC7-761753DE9D1CQ36934011-88B241C0-8C79-406E-A5C6-2DAE2FBB7E23Q38049711-2B3FA800-B3DA-4B7D-8BE4-DFAC23EFC501Q38109655-D884E442-2B11-43BC-BDA7-616D1C53DA5CQ38158004-B3D7CBBC-C762-4EFE-B67F-FAD1C94ECF9DQ38191058-FB5AD9F4-9D1A-446B-8E1D-B6E6740F2908Q38207680-E52D068A-F1DD-41B7-B1AB-11C053312C24Q38425458-6E6CFC22-1DB9-4432-B091-7E872A6AFDCDQ38803767-604F239F-3CDD-4CA5-AF3B-BDED8F211538Q38806920-5A678C4D-EAD7-43EE-A798-A489BDF79685Q39965038-CC44F64F-6CF0-4641-8927-7516D7B67F04Q40546517-0D47C732-E423-4AFF-A570-7110726266E9Q40776335-867B11A3-C632-4937-A198-66900BE3B086Q41335405-2F2CC1E2-B4DC-420C-806D-F4C1E3E6BED6Q42490902-B6588B81-90C7-41AC-9F0A-8E6017B066C4Q42505101-CAB0AADA-0996-4359-9B2F-6AD0158B13A6Q42516953-3BAFD49C-A421-4978-8047-CF98C1E88789Q42520026-00F2C012-53AA-4B87-BE65-39B0DE9C7BF7Q42552539-46737E59-13CB-464F-A963-23C8C8C7005FQ42967290-F5BF390C-C2B0-4190-B98A-94780B3CCCCDQ44547693-02F8E920-A42A-48D4-BC1B-54163523B518Q44850278-B8817981-726D-412D-9A2C-9D31D725D14DQ44854583-95E5E934-2096-451D-AFFF-5EB822F8EBF3Q45917509-318C3F79-C444-49A5-B4CE-10AEAAA9AD8BQ45968690-B27BB8F1-6A49-470F-9EE7-36724D6B97BAQ45969194-401A5621-8EC8-4B4E-B777-EFE444F552F0
P50
description
neuroscientist and researcher
@en
onderzoeker
@nl
name
Maria Trinidad Herrero
@ast
Maria Trinidad Herrero
@en
Maria Trinidad Herrero
@es
Maria Trinidad Herrero
@nl
type
label
Maria Trinidad Herrero
@ast
Maria Trinidad Herrero
@en
Maria Trinidad Herrero
@es
Maria Trinidad Herrero
@nl
altLabel
Herrero MT
@en
M T Herrero
@en
MARIA TRINIDAD HERRERO
@en
María Trinidad Herrero Ezquerro
@en
María Trinidad Herrero
@en
prefLabel
Maria Trinidad Herrero
@ast
Maria Trinidad Herrero
@en
Maria Trinidad Herrero
@es
Maria Trinidad Herrero
@nl
P1153
7102420100
P21
P31
P4012
P496
0000-0003-4953-1446